Synergy CHC (SNYR) Receivables - Other (2014 - 2025)

Synergy CHC's (SNYR) quarterly Receivables - Other came in at -$528506.0 in Q4 2025, down 126.43% year-on-year from $2.0 million in Q4 2024, and down 124.21% quarter-over-quarter from $2.2 million in Q3 2025.

Synergy CHC (SNYR) Receivables - Other (2014 - 2025) Analysis & Trends

Synergy CHC's Receivables - Other history runs 8 years deep, the most recent figure standing at -$528506.0 for Q4 2025.

  • On a quarterly basis, Receivables - Other fell 126.43% year-over-year to -$528506.0 in Q4 2025; TTM through Sep 2025 was $2.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.7 million, down 17.27% from the prior year.
  • Receivables - Other retreated to -$528506.0 in Q4 2025 per SNYR's latest filing, from $2.2 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $2.2 million in Q3 2025 and bottomed at -$528506.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Mckesson 105.15 Bn 101.18 Bn 4.04 Bn
2 Cencora 60.58 Bn 58.40 Bn 3.59 Bn
3 Cardinal Health 53.81 Bn 49.87 Bn 2.50 Bn
4 Henry Schein 9.71 Bn 9.57 Bn 1.07 Bn
5 Akso Health 3.28 Bn 3.28 Bn -
6 111 651.73 Mn 572.63 Mn 23.58 Mn
7 Accendra Health 248.02 Mn -88.86 Mn 278.03 Mn
8 Edap Tms 230.14 Mn 215.14 Mn 8.15 Mn
9 VitaNova Life Sciences 11.51 Mn 11.01 Mn 316,343.00
10 Synergy CHC 1.63 Mn -1.09 Mn 2.22 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -528,506.00
Dec 31, 2025 -528,506.00
Sep 30, 2025 2.18 Mn
Sep 30, 2025 2.18 Mn
Jun 30, 2025 2.03 Mn
Jun 30, 2025 2.03 Mn
Mar 31, 2025 1.86 Mn
Mar 31, 2025 1.86 Mn
Dec 31, 2024 2.00 Mn
Dec 31, 2024 2.00 Mn
Mar 31, 2020 470,984.00
Mar 31, 2020 470,984.00
Dec 31, 2019 277,432.00
Dec 31, 2019 277,432.00
Jun 30, 2019 120,660.00
Jun 30, 2019 120,660.00
Dec 31, 2017 559,243.00
Dec 31, 2017 559,243.00
Sep 30, 2017 3,814.00
Sep 30, 2017 3,814.00